Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring
Clinical trial NCT04460781 · COMPLETED
Trial details
- NCT number
- NCT04460781
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-17
- Primary completion
- 2022-02-28
- Enrollment
- 96175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.